glp 1 agonist lizard Did you know? The first GLP-1 medication for type 2 diabetes was inspired by a hormone found in the saliva of the Gila monster a venomous native to the southwestern US How a Desert Lizard Helped

Keep out of reach of children under 18

Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D)

Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof

Discover how GLP-1 drugs like semaglutide & tirzepatide are transforming obesity care with weight loss results rivaling bariatric surgery.

Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users